Meet the Start-ups

Sherif Idriss

Sherif Idriss | CEO | Elastin Bioscience

After an initial training as a pharmacist, 12 years ago, I was trained as a pharmacologist in Oxford then obtained a PhD in Neuroscience from University of Lubeck in Germany. With a highly diverse training in biomedical sciences, I worked as a postdoctoral fellow in University of Bern, to contribute to the drug discovery efforts for multiple sclerosis. After a few years in the biopharma consulting world, I joined Longaevus Technologies as an Entrepreneur in Residence. My project was a success and we established Elastin Biosciences.

Elastin BIosciences

Elastin Biosciences

Elastin Biosciences is a spin-off from Longaevus Technologies. We have pioneered a first-in-class Elastin-restoration platform technology, using small molecules. Using a single therapeutic and a combination-therapy approach, we have shown for the first time increased elastin expression in vivo combined with improved aortic structural integrity and function. Our technology has huge implications for elastin-deficiency diseases, as well as a huge potential for a wide range of applications.


Powered by:
Hyphen Projects   

    Connect     

Join Global Investor Forum

Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
         
 
 

                                    

          Register here
 
© Copyright 2023 by Hyphen Projects